MyoKardia (MYOK) News Today

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	Astria Therapeutics expands board with new director uk.investing.com - April 11 at 1:47 AM
	Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors finance.yahoo.com - April 9 at 8:56 AM
	FULC Fulcrum Therapeutics, Inc. seekingalpha.com - March 27 at 9:11 PM
	Cytokinetics: CEO Talks Down Buyout Prospects seekingalpha.com - March 16 at 7:08 AM
	Q4 2023 Fulcrum Therapeutics Inc Earnings Call uk.finance.yahoo.com - February 27 at 11:26 PM
	Fulcrum Therapeutics Inc (FULC) Reports Financial Results for Q4 and Full Year 2023 finance.yahoo.com - February 27 at 8:22 AM
	Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023 markets.businessinsider.com - February 27 at 8:22 AM
	If heart disease runs in your family, talk to your doctor about HCM cbsnews.com - February 16 at 10:23 AM
	Bristol Myers pours $100M into RNA drugs for cardiovascular diseases finance.yahoo.com - November 29 at 2:39 PM
	Avidity and BMS enter $2.3bn deal for cardiovascular targets msn.com - November 29 at 2:39 PM
	Why Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today? msn.com - November 28 at 2:17 PM
	Avidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments msn.com - November 28 at 9:17 AM
	How Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Faster forbes.com - November 22 at 9:22 AM
	Why LianBio Stock Is Ripping Higher Today benzinga.com - October 24 at 2:17 PM
	Why Is LianBio (LIAN) Stock Up 130% Today? msn.com - October 24 at 2:17 PM
	Why LianBio Stock Is Skyrocketing Today msn.com - October 24 at 2:17 PM
	LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets finance.yahoo.com - October 24 at 8:11 AM
	Bristol Myers (BMY) to Acquire Mirati Therapeutics for $5.8 B msn.com - October 9 at 12:59 PM
	Peninsula biotech company looks to pump new life into heart disease treatments bizjournals.com - October 4 at 6:08 PM
	Fulcrum Therapeutics (FULC) Price Target Increased by 30.97% to 10.78 msn.com - August 31 at 7:11 PM
	Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer finance.yahoo.com - July 27 at 10:44 AM
	Cutera Names Taylor Harris As CEO, Shares Gain markets.businessinsider.com - July 27 at 10:44 AM
	Cutera Names Taylor Harris CEO, Ending Succession Tussle >CUTR marketwatch.com - July 27 at 10:44 AM
	Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors finance.yahoo.com - July 11 at 2:00 PM
	EQS-News: Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors markets.businessinsider.com - July 11 at 2:00 PM
	Korporatsiya VSMPO AVISMA PAO (VSMO) investing.com - July 10 at 9:39 PM
	Hypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2023 uk.finance.yahoo.com - June 9 at 4:12 PM
	3 Dividend Stocks You Can Buy Without Any Hesitation msn.com - June 3 at 8:41 AM
	Tenaya Therapeutics, Inc.: Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update finanznachrichten.de - May 11 at 11:05 PM
	LianBio Announces Marketing Approval of CAMZYOS(R) (mavacamten) in the Macau Special Administrative Region (SAR) of China marketwatch.com - May 11 at 11:05 PM
	Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update technews.tmcnet.com - May 10 at 5:03 PM
	Diabetes Drug Therapy Market Analysis Report focuses on the remarkable market size CAGR rate of 4.6% for period from 2023 and 2030. marketwatch.com - April 13 at 2:03 PM
	Brain Ischemia market research report will assist market stakeholders in analysing the growing CAGR of 5.1% to make more informed decisions. marketwatch.com - April 13 at 8:57 AM
	The report on the Potassium Channel Blocker market assesses the competition, their advantages, and drawbacks, and predicts a CAGR of 5.3% by 2030. marketwatch.com - April 9 at 12:18 PM
	REGENCOR EXPANDS SCIENTIFIC ADVISORY BOARD benzinga.com - March 24 at 1:47 PM
	Cytokinetics heart failure drug turned back by FDA bizjournals.com - March 3 at 6:14 PM
	Dilated Cardiomyopathy Therapeutics Market Size, Share and Forecast 2028 with Top Countries Data marketwatch.com - February 24 at 4:41 AM
	Dilated Cardiomyopathy Therapeutics Market 2023: Growth Outlook and Forecast 2027 with Top Leaders, Size and Share Analysis marketwatch.com - February 6 at 1:50 PM
	Maze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chief Medical Officer - Yahoo Finance finance.yahoo.com - October 13 at 4:20 PM
	Maze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chie - Benzinga benzinga.com - October 13 at 10:40 AM
	Got $5,000? These 2 Stocks Could Continue Beating the Bear Market. - Nasdaq nasdaq.com - October 12 at 1:06 PM
	Bristol-Myers Squibb: A Gem Amid Macroeconomic Uncertainties - Seeking Alpha seekingalpha.com - October 2 at 10:18 AM
	Arthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures - StreetInsider.com streetinsider.com - September 27 at 11:03 AM
	Bristol Myers Squibb Stock: Still A Buy Despite Some Concerns (NYSE:BMY) - Seeking Alpha seekingalpha.com - September 11 at 8:17 AM
	Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer - StreetInsider.com streetinsider.com - September 8 at 2:31 AM
	Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer - Yahoo Finance finance.yahoo.com - September 7 at 4:30 PM
	Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer - Yahoo Finance finance.yahoo.com - August 24 at 6:38 PM
	Simcha Therapeutics Accelerates Growth with Key Leadership Appointments, Expanded Research and Option Agreement with Yale School of Medicine - Business Wire businesswire.com - August 18 at 4:58 AM
	Bristol Myers Squibb: Keep Buying On Good Performance (NYSE:BMY) - Seeking Alpha seekingalpha.com - August 12 at 6:10 PM
	LianBio Completes Enrollment in Pivotal Phase 3 EXPLORER-CN Trial of Mavacamten in Chinese Obstructive Hypertrophic Cardiomyopathy Patients - Yahoo Finance finance.yahoo.com - August 10 at 6:24 PM

Get MyoKardia News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MYOK Media Mentions By Week

MYOK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MYOK
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

MYOK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MYOK Articles
This Week
▼
0

0
▲
MYOK Articles
Average Week

Get MyoKardia News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:MYOK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MyoKardia (MYOK) News Today

MYOK Media Mentions By Week

MYOK Media Sentiment

MYOK News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info